| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |